Literature DB >> 1826550

An overview of the incidences and costs of low back pain.

J W Frymoyer1, W L Cats-Baril.   

Abstract

The basic premise of this article is that low back disorders are extremely prevalent in all societies, and probably have not increased substantially over the past two decades. What has increased is the rate of disability, the reasons for which are uncertain. Not only has this phenomenon heightened the awareness of low back pain, but it has led to an explosion in costs. Although a precise estimate is impossible, it is plausible that the direct medical and indirect costs of these conditions are in the range of more than $50 billion per annum, and could be as high as $100 billion at the extreme. Of these costs, 75% or more can be attributed to the 5% of people who become disabled temporarily or permanently from back pain--a phenomenon that seems more rooted in psychosocial rather than disease determinants. Within this overall equation, spinal surgery plays a relatively small role, although the contribution to disability probably has more than passing significance. The future challenge, if costs are to be controlled, appears to lie squarely with prevention and optimum management of disability, rather than perpetrating a myth that low back pain is a serious health disorder.

Entities:  

Mesh:

Year:  1991        PMID: 1826550

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN: 0030-5898            Impact factor:   2.472


  137 in total

1.  Cost-benefit and cost-effectiveness analysis of a disability prevention model for back pain management: a six year follow up study.

Authors:  P Loisel; J Lemaire; S Poitras; M-J Durand; F Champagne; S Stock; B Diallo; C Tremblay
Journal:  Occup Environ Med       Date:  2002-12       Impact factor: 4.402

2.  Development of a documentation instrument for the conservative treatment of spinal disorders in the International Spine Registry, Spine Tango.

Authors:  J T Kessler; M Melloh; Thomas Zweig; E Aghayev; C Röder
Journal:  Eur Spine J       Date:  2010-06-09       Impact factor: 3.134

3.  Kinematic response of lumbar functional spinal units to axial torsion with and without superimposed compression and flexion/extension.

Authors:  Hannes Haberl; Peter A Cripton; Tracy-E Orr; Thomas Beutler; Hanspeter Frei; Wolfgang R Lanksch; L-P Nolte
Journal:  Eur Spine J       Date:  2004-05-07       Impact factor: 3.134

4.  Bioavailability of oral carisoprodol 250 and 350 mg and metabolism to meprobamate: A single-dose crossover study.

Authors:  Steve Simon; Carrie D'Andrea; William J Wheeler; Harry Sacks
Journal:  Curr Ther Res Clin Exp       Date:  2010-02

5.  Psychosocial factors related to lower back problems in a South African manganese industry.

Authors:  Bernard van Vuuren; Evert Zinzen; Hendrik Johannes van Heerden; Piet Becker; Romain Meeusen
Journal:  J Occup Rehabil       Date:  2005-06

Review 6.  A hypothesis of chronic back pain: ligament subfailure injuries lead to muscle control dysfunction.

Authors:  Manohar M Panjabi
Journal:  Eur Spine J       Date:  2005-07-27       Impact factor: 3.134

Review 7.  Association between sitting and occupational LBP.

Authors:  Angela Maria Lis; Katia M Black; Hayley Korn; Margareta Nordin
Journal:  Eur Spine J       Date:  2006-05-31       Impact factor: 3.134

8.  Economic evaluation of a multi-stage return to work program for workers on sick-leave due to low back pain.

Authors:  Ivan A Steenstra; Johannes R Anema; Maurits W van Tulder; Paulien M Bongers; Henrica C W de Vet; Willem van Mechelen
Journal:  J Occup Rehabil       Date:  2006-12

9.  Effect of spinal manipulative therapy on mechanical pain sensitivity in patients with chronic nonspecific low back pain: a pilot randomized, controlled trial.

Authors:  Bryan M Bond; Chris D Kinslow; Adam W Yoder; Wen Liu
Journal:  J Man Manip Ther       Date:  2019-03-05

10.  Prevalence of musculoskeletal disorders among Indian railway sahayaks.

Authors:  Mohammed Rajik Khan; Nishant Kumar Singh
Journal:  Int J Occup Environ Health       Date:  2018-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.